drugset / Trial / NCT00000353

Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

NCT00000353 ↗

Treatment

Summary

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.

Timeline

Start
1996-10
Primary completion
1997-09
Completion
1997-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine/naloxone Unknown — Other

Indications